# Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)

> **NCT02152007** · PHASE1 · COMPLETED · sponsor: **TransDerm, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Pachyonychia Congenita

## Interventions

- **DRUG:** 1% sirolimus cream (TD201 1%)

## Key facts

- **NCT ID:** NCT02152007
- **Lead sponsor:** TransDerm, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-07
- **Final completion:** 2015-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02152007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02152007, "Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02152007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*